Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial

Griguer, C. E., Oliva, C. R., Coffey, C. S., Cudkowicz, M. E., Conwit, R. A., Gudjonsdottir, A. L., Ecklund, D. J., Fedler, J. K., Neill-Hudson, T. M., Nabors, L. B., Benge, M., Hackney, J. R., Chase, M., Leonard, T. P., Patel, T., Colman, H., de la Fuente, M., Chaudhary, R., Marder, K., … Markert, J. (2021). Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial. Neuro-Oncology Advances, 4(1). https://doi.org/10.1093/noajnl/vdab186
Authors:
Corinne E Griguer
Claudia R Oliva
Christopher S Coffey
Merit E Cudkowicz
Robin A Conwit
Anna L Gudjonsdottir
Dixie J Ecklund
Janel K Fedler
Tina M Neill-Hudson
Louis B Nabors
Melanie Benge
James R Hackney
Marianne Chase
Timothy P Leonard
Toral Patel
Howard Colman
Macarena De La Fuente
Rekha Chaudhary
Karen Marder
Teri Kreisl
Nimish Mohile
Milan G Chheda
Katharine Mcneill
Priya Kumthekar
Aclan Dogan
Jan Drappatz
Vinay Puduvalli
Agnes Kowalska
Jerome Graber
Elizabeth Gerstner
Stephen Clark
Michael Salacz
James Markert
Affiliated Authors:
Karen Marder
Teri Kreisl
Author Keywords:
biomarker
cytochrome c oxidase
glioblastoma
mgmt
prospective clinical trial
Publication Type:
Article
Unique ID:
10.1093/noajnl/vdab186
Publication Date:
Data Source:
Scopus

Record Created: